Eastwood Bio-Medical Canada Inc. (TSXV:EBM)

Canada flag Canada · Delayed Price · Currency is CAD
0.5900
+0.0400 (7.27%)
Oct 23, 2025, 3:58 PM EDT
7.27%
Market Cap40.64M
Revenue (ttm)594.57K
Net Income (ttm)-411.84K
Shares Out68.89M
EPS (ttm)-0.01
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume5,701
Average Volume1,496
Open0.6000
Previous Close0.5500
Day's Range0.5600 - 0.6000
52-Week Range0.2950 - 1.0000
Beta-0.14
RSI86.23
Earnings DateSep 26, 2025

About TSXV:EBM

Eastwood Bio-Medical Canada Inc. markets and distributes natural health products under the Eleotin brand in Canada, the United States, and Asia. The company distributes Eleotin, which provides natural remedies for metabolic disorders, such as blood glucose disorders, hypertension, and obesity. Its licensed products include Eleotin A 700 for the treatment for spleen deficiency, lack of appetite, and fatigue; Eleotin AL88 for laxative; Eleotin Cal20 for bone and teeth maintenance; Eleotin V3D for development and maintenance of bones, teeth, and g... [Read more]

Founded 2010
Country Canada
Stock Exchange TSX Venture Exchange
Ticker Symbol EBM
Full Company Profile

Financial Performance

In 2024, TSXV:EBM's revenue was 702,076, a decrease of -19.11% compared to the previous year's 867,936. Losses were -455,870, -16.60% less than in 2023.

Financial Statements

News

There is no news available yet.